Charles River Laboratories Chief Scientific and Innovation Officer Dr. Namandjé Bumpus published an Eureka Blog exploring how integrating in vivo, in vitro, and in silico approaches shapes the next era of nonclinical science.
Public source
Publisher name
Public post
Scientific discovery is strongest when disciplines, technologies, and expertise come together. In her latest #EurekaBlog, Dr. Namandjé Bumpus, PhD, Chief Scientific and…
Company
Charles River Laboratories
Together, We Create Healthier Lives
- Industry
- Biotechnology Research
- Location
- Wilmington, US
- Company size
- 10,001+ employees
About Charles River Laboratories
At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all possible. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL
See moreLatest activity
Latest activity from Charles River Laboratories
47 signals
Products & Services
Charles River Laboratories released a fully automated cartridge production suite for bacterial endotoxin testing to drive greater quality, efficiency, traceability, and scalability.
People
Charles River Laboratories welcomed interns like Nokutenda Chelsea Choto to gain hands-on experience while discovering the people, culture, and sense of community that make Charles River special.
Research & Knowledge
Charles River Laboratories launched The DART Board, a new EurekaBlog series spotlighting topics in developmental and reproductive toxicology, including the inaugural article Why Every Ovarian Follicle Count Matters.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
PhoenixBio
PhoenixBio published a blog post discussing how species differences in CYP enzymes and liver transporters impact drug metabolism and highlights approaches for translatable data on metabolic clearance, DDI, and more.
Research & Knowledge
Lovelace Biomedical
Lovelace Biomedical published a blog post titled 'The goal is not the largest possible dataset. It is the information needed to support the next meaningful decision' that highlights the importance of fast, clean answers in drug development.
Research & Knowledge
ScitoVation
ScitoVation published a new issue of ScitoVation Insight exploring the FDA's approach to New Approach Methodologies (NAMs) and what sponsors need to know.
Research & Knowledge
Microbiologics
Microbiologics published a commentary in Regulatory Toxicology and Pharmacology by 24 authors from FDA, The National Institutes of Health, the 3Rs Centre Utrecht, the National Institute of Health Sciences in Japan, large pharma, consulting, industry and academia.
Research & Knowledge
VivoSim Labs, Inc.